Goal 2: Reduce Human Disease

Phase III efficacy trials of tuberculosis drugs

1) Phase III efficacy trials of new tuberculosis drugs (e.g., bedaquiline, delamanid, PA-824) that have shown promise in early phase studies for multidrug-resistant tuberculosis.

 

2) Phase III efficacy trials of new and existing tuberculosis drugs to development very short course regimens (3-4 months).

 

3) Phase III efficacy trials of new and existing drugs for treatment of latent tuberculosis infection in contacts of persons with multidrug-resistant tuberculosis.

Tags (Keywords associated with the idea)

Voting

1 net vote
1 up votes
0 down votes
Active
Idea No. 1623